CRYOPORT, INC. Stock Issued During Period, Shares, Issued for Services
CRYOPORT, INC. (CYRX) had Stock Issued During Period, Shares, Issued for Services of 562.50 thousand shares as of 2019-06-24, per its 10-K filed 2022-02-28.
Discontinued › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesIssuedForServices · last filed 2022-02-28
- 2019-06-24: Stock Issued During Period, Shares, Issued for Services 562.50K shares.
- 2016-10-28: Stock Issued During Period, Shares, Issued for Services 1 month 2.47M shares.
- 2014-02-28: Stock Issued During Period, Shares, Issued for Services 1 month 150.00K shares.
| Period end | Stock Issued During Period, Shares, Issued for Services | Stock Issued During Period, Shares, Issued for Services 1 month |
|---|---|---|
| 2019-06-24 | 562.50K shares 10-K · filed 2022-02-28 | |
| 2016-10-28 | 2.47M shares 10-K · filed 2018-03-08 | |
| 2014-02-28 | 150.00K shares 10-Q · filed 2015-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |